ANIK

ANIK Stock-Based Compensation

$13.15MTTM · USD

Period ending:

ANIK FY Stock-Based CompUSD
ANIK FY Stock-Based Comp1993-08-31: $0.001994-08-31: $0.001995-08-31: $0.001996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $0.002003-12-31: $0.002004-12-31: $0.002005-12-31: $0.002006-12-31: $1.27B2007-12-31: $911.72M2008-12-31: $1.39M2009-12-31: $958.03K2010-12-31: $1.10M2011-12-31: $1.19M2012-12-31: $1.15M2013-12-31: $1.27M2014-12-31: $1.61M2015-12-31: $2.23M2016-12-31: $3.39M2017-12-31: $5.81M2018-12-31: $11.05M2019-12-31: $6.09M2020-12-31: $0.002021-12-31: $11.09M2022-12-31: $14.32M2023-12-31: $15.24M2024-12-31: $13.13M2025-12-31: $10.08M$1.27B$0.00
1993-08-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANIK stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 33 observations from Aug 31, 1993 to Dec 31, 2025.

Anika Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
10,084,000
13,130,000
15,243,000
14,315,000
11,085,000
0
6,087,000
11,046,000
5,807,000
3,392,000
2,225,000
1,607,421
1,268,070
1,151,199
1,190,697
1,102,617
958,025
1,391,704
911,716,000
1,267,205,000
0
0
0
0
0
0
0
0
0
0
0
0
0

Compare stock-based compensation

All ANIK financial metrics · ANIK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.